10:01 AM EDT, 10/23/2025 (MT Newswires) -- Tango Therapeutics ( TNGX ) said Thursday it priced an underwritten offering of over 21 million shares and pre-funded warrants to buy up to around 3.2 million shares, for expected gross proceeds of $210 million.

The offering price of each share is $8.66, and the offering price of each pre-funded warrant is $8.659, the company said.

Simultaneously with the offering, Tango has signed a securities purchase agreement for a private investment in public equity, or PIPE, deal for the sale of more than 1.7 million shares at $8.66 per share, for expected gross proceeds of around $15 million.

The offering and the PIPE deal are expected to close on or about Friday, it said.

Tango shares were down about 14% in recent trading.

Price: 7.49, Change: -1.17, Percent Change: -13.51